Long-Term Follow-up of the West of Scotland Coronary Prevention Study
Top Cited Papers
Open Access
- 11 October 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (15) , 1477-1486
- https://doi.org/10.1056/nejmoa065994
Abstract
The West of Scotland Coronary Prevention Study was a randomized clinical trial comparing pravastatin with placebo in men with hypercholesterolemia who did not have a history of myocardial infarction, with an average follow-up of approximately 5 years. The combined outcome of death from definite coronary heart disease or definite nonfatal myocardial infarction was reduced from 7.9 to 5.5% (P<0.001) in the treatment group. Extended follow-up data were obtained for approximately 10 years after completion of the trial.Keywords
This publication has 17 references indexed in Scilit:
- Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)The Lancet, 2004
- Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-upThe Lancet, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Computerised record linkage: Compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological studyJournal of Clinical Epidemiology, 1995
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Screening experience and baseline characteristics in the West of Scotland coronary prevention studyThe American Journal of Cardiology, 1995
- Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol LevelsCirculation, 1995
- Deprivation and mortality in Scotland, 1981 and 1991BMJ, 1994
- A coronary primary prevention study of Scottish men aged 45?64 years: Trial designJournal of Clinical Epidemiology, 1992